Sartorius | SRT3 - Net Income

Stock Price
204.90
Daily Change
-8.60 -4.03%
Monthly
-10.13%
Yearly
-11.22%
Q2 Forecast
211.37

Sartorius reported EUR56.2M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.16M 108K Sep/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Ionis Pharmaceuticals USD -93M 136M Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
Moderna USD -1.34B 517M Mar/2026
Organon & Co USD -205M 365M Dec/2025
Revvity USD 40.72M 57.65M Mar/2026
Sartorius EUR 56.2M 37M Mar/2026
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Viatris USD 176.4M 516.5M Mar/2026
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025